The 10-Year Health Plan marks a significant step forward in building an NHS that is faster, fairer and fit for the future. At NICE, we’re ready to deliver - using our expanded remit to accelerate ...

Home NICE Guidance Conditions and diseases Blood and immune system conditions Blood and bone marrow cancers Belantamab mafodotin with bortezomib and dexamethasone for treating relapsed or refractory ...

The evaluation committee will meet again to consider the evidence, this evaluation consultation document and comments from the stakeholders. At that meeting, the committee will also consider comments ...

The FDG has been sent to consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it and/or notify us of any factual errors. The FDG has been sent to ...

The new approach will ensure that high-impact devices, diagnostics and digital tools recommended by NICE, that meet the most urgent needs, are nationally reimbursed and made available across the NHS - ...

In this guest blog, Dale Greenwood, mental health lead for East London NHS Foundation Trust, shares how his trust implemented ...

Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults. Last reviewed: 18 June 2025 Next review: This guidance will be reviewed if there is ...

The draft guideline recommends medicines be given up to a year earlier - helping people live well for longer. We’re updating the recommendations for drug treatments in our clinical guideline on the ...

Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional cost to the NHS The benefits from donanemab (also called Kisunla and made by Eli Lilly) and ...

02 July 2025 Zoom Draft Agenda The meeting will take place as a meeting via Zoom, a secure web conferencing tool. This meeting will run from 9:00am to 5:00pm, although timings may be subject to change ...

Home NICE guidance In development PillCam COLON 2 for investigation of the colon through direct visualisation ...